Abstract
Biotechnology Law ReportVol. 25, No. 6 TextsGuidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious DiseasesPublished Online:5 Jan 2007https://doi.org/10.1089/blr.2006.25.697AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byGadolinium retention in the ischemic cerebrum: Implications for pain, neuron loss, and neurological deficits15 September 2022 | Magnetic Resonance in Medicine, Vol. 89, No. 1Anacardium occidentale Bark as an Antidiabetic Agent7 October 2022 | Plants, Vol. 11, No. 19Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicityLife Sciences, Vol. 305Quantification of Phosphonate Drugs by 1 H– 31 P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than Mice6 July 2022 | Analytical Chemistry, Vol. 94, No. 28Cocoa (Theobroma cacao L.) Seed-Derived Peptides Reduce Blood Pressure by Interacting with the Catalytic Site of the Angiotensin-Converting Enzyme30 September 2021 | Foods, Vol. 10, No. 10Tocotrienols as an Anti-Breast Cancer Agent29 August 2021 | Antioxidants, Vol. 10, No. 9Polyphenols-Rich Fruit (Euterpe edulis Mart.) Prevents Peripheral Inflammatory Pathway Activation by the Short-Term High-Fat Diet27 April 2019 | Molecules, Vol. 24, No. 9The Use of Juçara (Euterpe edulis Mart.) Supplementation for Suppression of NF-κB Pathway in the Hypothalamus after High-Fat Diet in Wistar Rats21 July 2018 | Molecules, Vol. 23, No. 7Toward a unifying strategy for the structure-based prediction of toxicological endpoints9 November 2015 | Archives of Toxicology, Vol. 90, No. 10Cloning and assessment of tumorigenicity and oncogenicity of a Madin–Darby canine kidney (MDCK) cell line for influenza vaccine productionVaccine, Vol. 28, No. 5 Volume 25Issue 6Dec 2006 InformationCopyright 2006, Mary Ann Liebert, Inc.To cite this article:Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases.Biotechnology Law Report.Dec 2006.697-723.http://doi.org/10.1089/blr.2006.25.697Published in Volume: 25 Issue 6: January 5, 2007PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
